Skip to main content

AIS clinical trials at UC Health
1 research study open to new patients

  • NBP in Adult Patients With Acute Ischemic Stroke (AIS)

    open to eligible people ages 18-85

    This is a Phase 2 multicenter, randomized, double-blind, placebo-controlled, add-on to standard of care study of NBP softgel capsules for the treatment of mild to moderate AIS in adults.

    at UCLA

Last updated: